"But, currently RVX is being tiraled in population with diabetes not heart failure. These are 2 diff. populations."

The point being is that in general as I understand it, people with diabetes will die from some sort of heart disease, congestive heart failure (CHF) being one of them or at least being hospitalized for CHF. The standard of care for diabetes using Empagliflozin in combination with Apabetalone BOM clinical trial showed that there is a 41% Harazard Reduction with a P-Value of 0.03 in patients hospitalized suffering from Congestive Heart failure.

Koo